Roderick Wong - 16 Jun 2021 Form 4 Insider Report for Avidity Biosciences, Inc. (RNA)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: RNA
Reported as of: 16 Jun 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Jun 2021, 12:53:13 UTC
Prior SEC filing: 16 Jun 2021
Next SEC filing: 31 Aug 2021
Source filing: View source filing
Reporting owner signature: /s/ John W. Wallen III, Ph.D., J.D., Attorney-in-Fact

Key filing fact

Roderick Wong filed Form 4 for Avidity Biosciences, Inc. (RNA) on 17 Jun 2021.

Key facts

This page summarizes Roderick Wong's Form 4 filing for Avidity Biosciences, Inc. (RNA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Jun 2021, 12:53.

Change

Previous filing in this sequence was filed on 16 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RNA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +15,000
Change %
Price: $0.000000
Shares after: 15,000
Date: 16 Jun 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,000
Exercise price: $26.09
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option shall vest on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date.